LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 - Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
|
Company dealt in | AON PLC |
|
Class of relevant security to which the | ORD |
|
dealings being disclosed relate (Note 2) | ||
Date of dealing | 30 June 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
234,560 |
0.10% |
1,477,549 |
0.64% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
521,650 |
0.23% |
29,700 |
0.01% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 2,600 |
0.00% |
5,000 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
758,810 |
0.33% |
1,512,249 |
0.65% |
||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 22 |
191.4500 USD |
Purchase | 28 |
187.5678 USD |
Purchase | 45 |
192.5800 USD |
Purchase | 72 |
190.9456 USD |
Purchase | 100 |
192.6300 USD |
Purchase | 100 |
192.5900 USD |
Purchase | 100 |
191.1074 USD |
Purchase | 101 |
191.1900 USD |
Purchase | 139 |
187.6900 USD |
Purchase | 200 |
193.1350 USD |
Purchase | 265 |
191.2801 USD |
Purchase | 272 |
188.6735 USD |
Purchase | 415 |
190.4818 USD |
Purchase | 500 |
190.7700 USD |
Purchase | 632 |
192.5658 USD |
Purchase | 700 |
190.4992 USD |
Purchase | 880 |
190.6393 USD |
Purchase | 1,000 |
190.4650 USD |
Purchase | 1,742 |
191.2356 USD |
Purchase | 1,900 |
192.1500 USD |
Purchase | 2,072 |
192.5975 USD |
Purchase | 4,740 |
190.5476 USD |
Purchase | 5,140 |
190.4694 USD |
Purchase | 7,489 |
189.8009 USD |
Purchase | 8,556 |
192.6000 USD |
Purchase | 35,778 |
192.3691 USD |
Purchase | 55,682 |
191.5067 USD |
Sale | 6 |
192.4500 USD |
Sale | 14 |
191.0600 USD |
Sale | 15 |
191.2766 USD |
Sale | 18 |
191.2000 USD |
Sale | 22 |
191.4500 USD |
Sale | 25 |
190.3100 USD |
Sale | 48 |
191.7300 USD |
Sale | 82 |
191.0870 USD |
Sale | 100 |
192.7600 USD |
Sale | 100 |
192.6600 USD |
Sale | 100 |
190.9000 USD |
Sale | 100 |
189.7700 USD |
Sale | 101 |
190.5800 USD |
Sale | 185 |
191.2051 USD |
Sale | 200 |
191.6650 USD |
Sale | 213 |
188.1454 USD |
Sale | 345 |
190.5975 USD |
Sale | 477 |
191.5497 USD |
Sale | 600 |
188.1633 USD |
Sale | 600 |
192.7883 USD |
Sale | 625 |
192.2160 USD |
Sale | 812 |
191.4094 USD |
Sale | 1,337 |
192.6099 USD |
Sale | 1,516 |
192.1632 USD |
Sale | 1,621 |
191.8503 USD |
Sale | 1,810 |
192.5415 USD |
Sale | 2,100 |
192.5305 USD |
Sale | 2,174 |
190.4824 USD |
Sale | 2,380 |
192.2509 USD |
Sale | 2,840 |
191.1139 USD |
Sale | 2,900 |
189.9646 USD |
Sale | 4,240 |
190.8769 USD |
Sale | 8,705 |
191.0581 USD |
Sale | 10,981 |
192.6000 USD |
Sale | 18,016 |
191.5645 USD |
Sale | 20,178 |
191.3301 USD |
Sale | 44,513 |
191.8937 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 2 Jul 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or |
Number of |
Exercise |
Type |
Expiry |
purchased |
relevant securities |
price |
|
date |
|
|
to which the option |
|
|
|
|
|
or derivative |
|
|
|
|
|
relates |
|
|
|
|
Put Options | Purchased |
-500 |
140.0000 |
American |
Jun 30, 2020 |
Call Options | Purchased |
1,100 |
260.0000 |
American |
Jul 17, 2020 |
Call Options | Purchased |
1,500 |
240.0000 |
American |
Jul 17, 2020 |
Call Options | Written |
-4,500 |
220.0000 |
American |
Jul 17, 2020 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.